Page last updated: 2024-11-13
penimepicycline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
penimepicycline : A penicillinate salt obtained by combining equimolar amounts of phenoxymethylpenicillin and pipacycline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 54686187 |
CHEMBL ID | 3833378 |
CHEBI ID | 75258 |
SCHEMBL ID | 1649330 |
MeSH ID | M0047037 |
Synonyms (31)
Synonym |
---|
penimepicycline (inn) |
4599-60-4 |
D07233 |
penimepicyclinum [inn-latin] |
penimepicycline [inn:dcf] |
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-n-((4-(2-hydroxyethyl)-1-piperazinyl)methyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide salt with phenoxymethylpenicillin |
mepicycline penicillinate |
penimepicycline |
duamine |
penimepiciclina [dcit] |
einecs 225-002-0 |
penetracyne |
hydrocycline |
CHEBI:75258 |
pipacycline-penicillin v |
pipacycline/penicillin v |
penimepiciclina |
penimepicyclinum |
unii-3rgq4b6e87 |
3rgq4b6e87 , |
penimepicycline [who-dd] |
geotricyn |
penimepicycline [inn] |
criseocil |
penimepicycline [mi] |
SCHEMBL1649330 |
CHEMBL3833378 |
DTXSID20905088 |
Q4924638 |
DB13264 |
(4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-n-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.11
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.11) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |